表紙
市場調查報告書

血漿替換療法的全球市場

Therapeutic Plasma Exchange

出版商 Global Industry Analysts, Inc. 商品編碼 893763
出版日期 內容資訊 英文 141 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血漿替換療法的全球市場 Therapeutic Plasma Exchange
出版日期: 2019年10月01日內容資訊: 英文 141 Pages
簡介

本報告提供全球血漿替換療法 (TPE)的市場相關分析,整體市場規模的成果值、預測值,及主要推動及阻礙市場要素,各最終用途、各適應症及各企業的市場佔有率趨勢 (過去9年、今後8年份),今後的市場成長的方向性,各地區、主要國家的市場詳細趨勢等調查,再加上主要企業簡介等資訊。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值、預測值)
    • 各種類的市場佔有率結構 (最新值、預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模、佔有率趨勢預測:各地區/國家
    • 醫院用
      • 市場規模 (過去9年、今後8年份)
      • 市場佔有率:各企業 (總計17年份)
    • 專門醫院
    • 當天返回手術中心 (ASC)
    • 神經疾病
    • 腎臟疾病
    • 血液疾病
    • 代謝異常
    • 其他的疾病

第3章 市場分析

  • 各地區的市場分析
    • 美國
      • 市場基本資料
      • 液晶替換療法 (TPE)的市場規模 (成果值、預測值)
      • 各企業市場佔有率
      • 各最終用途、各適應症的市場規模 (成果值、預測值)
    • 加拿大
    • 日本
    • 中國
    • 歐洲
      • 法國
      • 德國
      • 義大利
      • 英國
      • 其他
    • 亞太地區
    • 其他的國家 (RoW)

第4章 企業

  • 旭化成醫學
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL
  • FENWAL, INC.
  • FRESENIUS SE & CO. KGAA
  • HAEMONETICS CORPORATION
  • HEMACARE CORPORATION
  • 川澄化學工業
  • Terumo CorporationBCT

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP15189

Therapeutic Plasma Exchange market worldwide is projected to grow by US$663.8 Million, driven by a compounded growth of 7%. Neurological Disorders, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$616 Million by the year 2025, Neurological Disorders will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$30.1 Million to the region's size and clout in the next 5 to 6 years. Over US$31.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Neurological Disorders will reach a market size of US$56.2 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.7% over the next couple of years and add approximately US$113.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International, Inc.; Fenwal, Inc.; Fresenius SE & Co. KGaA; Haemonetics Corporation; HemaCare Corporation; Kawasumi Laboratories, Inc.; Terumo BCT, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Therapeutic Plasma Exchange Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Therapeutic Plasma Exchange Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Therapeutic Plasma Exchange Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Therapeutic Plasma Exchange Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Hospitals (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025
  • TABLE 5: Hospitals (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017
  • TABLE 6: Hospitals (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 7: Specialty Clinics (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
  • TABLE 8: Specialty Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017
  • TABLE 9: Specialty Clinics (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 10: Ambulatory Surgical Centers (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 11: Ambulatory Surgical Centers (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017
  • TABLE 12: Ambulatory Surgical Centers (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 13: Neurological Disorders (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 14: Neurological Disorders (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 15: Neurological Disorders (Disease Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Renal Disorders (Disease Indication) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 17: Renal Disorders (Disease Indication) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 18: Renal Disorders (Disease Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 19: Hematology Disorders (Disease Indication) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 20: Hematology Disorders (Disease Indication) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 21: Hematology Disorders (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Metabolic Disorders (Disease Indication) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 23: Metabolic Disorders (Disease Indication) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 24: Metabolic Disorders (Disease Indication) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Other Disease Indications (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 26: Other Disease Indications (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 27: Other Disease Indications (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Therapeutic Plasma Exchange Market Share (in %) by Company: 2019 & 2025
    • TABLE 28: United States Therapeutic Plasma Exchange Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 29: Therapeutic Plasma Exchange Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017
    • TABLE 30: Therapeutic Plasma Exchange Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
    • TABLE 31: United States Therapeutic Plasma Exchange Market Estimates and Projections in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 32: Therapeutic Plasma Exchange Market in the United States by Disease Indication: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 33: United States Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 34: Canadian Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 35: Therapeutic Plasma Exchange Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017
    • TABLE 36: Canadian Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 37: Canadian Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 38: Canadian Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017
    • TABLE 39: Therapeutic Plasma Exchange Market in Canada: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025
  • JAPAN
    • TABLE 40: Japanese Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 41: Japanese Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017
    • TABLE 42: Therapeutic Plasma Exchange Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
    • TABLE 43: Japanese Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 44: Therapeutic Plasma Exchange Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017
    • TABLE 45: Japanese Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 46: Chinese Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 47: Therapeutic Plasma Exchange Market Review in China in US$ Thousand by End-Use: 2009-2017
    • TABLE 48: Chinese Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 49: Chinese Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 50: Therapeutic Plasma Exchange Historic Market Analysis in China in US$ Thousand by Disease Indication: 2009-2017
    • TABLE 51: Chinese Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Therapeutic Plasma Exchange Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 52: European Therapeutic Plasma Exchange Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 53: Therapeutic Plasma Exchange Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 54: European Therapeutic Plasma Exchange Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: European Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025
    • TABLE 56: Therapeutic Plasma Exchange Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017
    • TABLE 57: European Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 58: European Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025
    • TABLE 59: Therapeutic Plasma Exchange Market in Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017
    • TABLE 60: European Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 61: Therapeutic Plasma Exchange Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025
    • TABLE 62: French Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017
    • TABLE 63: French Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 64: Therapeutic Plasma Exchange Market in France by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 65: French Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017
    • TABLE 66: French Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 67: Therapeutic Plasma Exchange Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025
    • TABLE 68: German Therapeutic Plasma Exchange Market in Retrospect in US$ Thousand by End-Use: 2009-2017
    • TABLE 69: Therapeutic Plasma Exchange Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
    • TABLE 70: Therapeutic Plasma Exchange Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 71: German Therapeutic Plasma Exchange Historic Market Analysis in US$ Thousand by Disease Indication: 2009-2017
    • TABLE 72: German Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 73: Italian Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 74: Therapeutic Plasma Exchange Market Review in Italy in US$ Thousand by End-Use: 2009-2017
    • TABLE 75: Italian Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 76: Italian Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 77: Therapeutic Plasma Exchange Historic Market Analysis in Italy in US$ Thousand by Disease Indication: 2009-2017
    • TABLE 78: Italian Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 80: United Kingdom Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017
    • TABLE 81: Therapeutic Plasma Exchange Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
    • TABLE 82: United Kingdom Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 83: Therapeutic Plasma Exchange Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017
    • TABLE 84: United Kingdom Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025
    • TABLE 86: Therapeutic Plasma Exchange Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017
    • TABLE 87: Rest of Europe Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 88: Rest of Europe Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025
    • TABLE 89: Therapeutic Plasma Exchange Market in Rest of Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017
    • TABLE 90: Rest of Europe Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 91: Therapeutic Plasma Exchange Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025
    • TABLE 92: Asia-Pacific Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017
    • TABLE 93: Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 94: Therapeutic Plasma Exchange Market in Asia-Pacific by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 95: Asia-Pacific Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017
    • TABLE 96: Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 97: Rest of World Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 98: Therapeutic Plasma Exchange Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017
    • TABLE 99: Rest of World Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 100: Rest of World Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 101: Rest of World Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017
    • TABLE 102: Therapeutic Plasma Exchange Market in Rest of World: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025

IV. COMPETITION

  • ASAHI KASEI MEDICAL
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL
  • FENWAL, INC.
  • FRESENIUS SE & CO. KGAA
  • HAEMONETICS CORPORATION
  • HEMACARE CORPORATION
  • KAWASUMI LABORATORIES
  • TERUMO BCT

V. CURATED RESEARCH

Back to Top